Photodynamic therapy for angiosarcoma of scalp as alternative approach for surgical treatment in patient with severe co-morbidity

<p>A case of successful photodynamic therapy in patient of 86 y.o. with diagnosis: angiosarcoma of right temporal-parietal region stage IIA (Т<sub>2в</sub>N<sub>0</sub>M<sub>0</sub>) is reported. The tumor was as soft tissue round shape lesion with tuberous...

Full description

Bibliographic Details
Main Authors: E. V. Yaroslavtseva-Isaeva, M. A. Kaplan
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2014-01-01
Series:Biomedical Photonics
Subjects:
Online Access:http://www.pdt-journal.com:80/jour/article/view/45
_version_ 1819042524672557056
author E. V. Yaroslavtseva-Isaeva
M. A. Kaplan
author_facet E. V. Yaroslavtseva-Isaeva
M. A. Kaplan
author_sort E. V. Yaroslavtseva-Isaeva
collection DOAJ
description <p>A case of successful photodynamic therapy in patient of 86 y.o. with diagnosis: angiosarcoma of right temporal-parietal region stage IIA (Т<sub>2в</sub>N<sub>0</sub>M<sub>0</sub>) is reported. The tumor was as soft tissue round shape lesion with tuberous contours 3.4х3.4х1.1 cm in size, located in subcutaneous tissue in right parietal region with no scull bone invasion. The patient was refused to surgical treatment with general anesthesia due to severe cardiovascular co-morbidity. The patient underwent a course of photodynamic therapy with Photolon. The photosensitizer was intravenousely introduced for 3 h before irradiation at dose of 1 mg/kg body weight. The parameters of irradiation were as follows: output power – 0.8 W, light dose – 150 J/cm<sup>2</sup>, 4 irradiation fields 2.5 cm in diameter. During the irradiation there were moderate pain which did not require drug management. After PDT complete regression of the tumor was achieved. For nowadays (11 months after treatment) the patient is observed with no recurrence. The reported case shows that photodynamic therapy may be successfully used for alternative treatment of soft tissue angiosarcoma in patients with no ability for surgical treatment.</p><p> </p>
first_indexed 2024-12-21T09:42:16Z
format Article
id doaj.art-16b9a1a5f1c946f3a7781094526bc5b7
institution Directory Open Access Journal
issn 2413-9432
language Russian
last_indexed 2024-12-21T09:42:16Z
publishDate 2014-01-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj.art-16b9a1a5f1c946f3a7781094526bc5b72022-12-21T19:08:26ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322014-01-0133313343Photodynamic therapy for angiosarcoma of scalp as alternative approach for surgical treatment in patient with severe co-morbidityE. V. Yaroslavtseva-Isaeva0M. A. Kaplan1Национальный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, Россия<p>A case of successful photodynamic therapy in patient of 86 y.o. with diagnosis: angiosarcoma of right temporal-parietal region stage IIA (Т<sub>2в</sub>N<sub>0</sub>M<sub>0</sub>) is reported. The tumor was as soft tissue round shape lesion with tuberous contours 3.4х3.4х1.1 cm in size, located in subcutaneous tissue in right parietal region with no scull bone invasion. The patient was refused to surgical treatment with general anesthesia due to severe cardiovascular co-morbidity. The patient underwent a course of photodynamic therapy with Photolon. The photosensitizer was intravenousely introduced for 3 h before irradiation at dose of 1 mg/kg body weight. The parameters of irradiation were as follows: output power – 0.8 W, light dose – 150 J/cm<sup>2</sup>, 4 irradiation fields 2.5 cm in diameter. During the irradiation there were moderate pain which did not require drug management. After PDT complete regression of the tumor was achieved. For nowadays (11 months after treatment) the patient is observed with no recurrence. The reported case shows that photodynamic therapy may be successfully used for alternative treatment of soft tissue angiosarcoma in patients with no ability for surgical treatment.</p><p> </p>http://www.pdt-journal.com:80/jour/article/view/45ангиосаркома мягких тканейфотодинамическая терапияальтернативное лечениефотолон
spellingShingle E. V. Yaroslavtseva-Isaeva
M. A. Kaplan
Photodynamic therapy for angiosarcoma of scalp as alternative approach for surgical treatment in patient with severe co-morbidity
Biomedical Photonics
ангиосаркома мягких тканей
фотодинамическая терапия
альтернативное лечение
фотолон
title Photodynamic therapy for angiosarcoma of scalp as alternative approach for surgical treatment in patient with severe co-morbidity
title_full Photodynamic therapy for angiosarcoma of scalp as alternative approach for surgical treatment in patient with severe co-morbidity
title_fullStr Photodynamic therapy for angiosarcoma of scalp as alternative approach for surgical treatment in patient with severe co-morbidity
title_full_unstemmed Photodynamic therapy for angiosarcoma of scalp as alternative approach for surgical treatment in patient with severe co-morbidity
title_short Photodynamic therapy for angiosarcoma of scalp as alternative approach for surgical treatment in patient with severe co-morbidity
title_sort photodynamic therapy for angiosarcoma of scalp as alternative approach for surgical treatment in patient with severe co morbidity
topic ангиосаркома мягких тканей
фотодинамическая терапия
альтернативное лечение
фотолон
url http://www.pdt-journal.com:80/jour/article/view/45
work_keys_str_mv AT evyaroslavtsevaisaeva photodynamictherapyforangiosarcomaofscalpasalternativeapproachforsurgicaltreatmentinpatientwithseverecomorbidity
AT makaplan photodynamictherapyforangiosarcomaofscalpasalternativeapproachforsurgicaltreatmentinpatientwithseverecomorbidity